Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-21-001068
Filing Date
2021-10-19
Accepted
2021-10-19 17:23:55
Documents
2
Group Members
ORBIMED CAPITAL GP VII LLCORBIMED GENESIS GP LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss560672_sc13d.htm SC 13D 112067
2 JOINT FILING AGREEMENT ss560672_ex9901.htm EX-99.1 6686
  Complete submission text file 0000947871-21-001068.txt   120281
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Subject) CIK: 0001745020 (see all company filings)

EIN.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92944 | Film No.: 211331994
SIC: 2834 Pharmaceutical Preparations